MarketBeat on MSN
Is Abbott's January pullback a good time to buy?
Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven ...
Investing.com -- Abbott Laboratories (NYSE:ABT) reported fourth-quarter earnings that met expectations but missed on revenue, ...
Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...
Abbott's Medical Devices segment, especially CGM, continues to deliver robust double-digit growth, offsetting Nutrition ...
InvestorsHub on MSN
Abbott shares slide after Q4 revenue comes in short, outlook disappoints
Abbott Laboratories (NYSE:ABT) shares fell about 4.8% after the company reported fourth-quarter results that met earnings ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Texas Gov. Greg Abbott announced he tested positive for COVID-19 on Tuesday despite being fully vaccinated. "I test myself every day and today is the first day that I tested positive," Gov. Abbott ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results